|
| Curative effect of invigorating spleen and tonifying kidney Chinese herb in patients with pulmonary carcinoma after perfusion chemotherapy |
| Hits 1849 Download times 1822 Received:March 17, 2011 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2011.05.09 |
| Key Words
invigorating spleen and tonifying kidney Chinese herb;pulmonary carcinoma;treatment of integrated traditional Chinese medicine and Western medicine;recent effect |
| Author Name | Affiliation | | YUAN Jing-bo | Radiology Department of Hebei Province TCM Hospital, Shijiazhuang 050011, China | | SU Chun-zhi | Gastroenterology Department of Hebei Province TCM Hospital, Shijiazhuang 050011, China | | LI Guang-rong | Hebei Speaal care Hospital, Shijiazhuang 050011, China | | 刘兆勋 | Hebei Speaal care Hospital, Shijiazhuang 050011, China |
|
| Abstract
|
| [Objective] To observe the therapeutic effect of traditional Chinese medicine combined with local perfusion chemotherapy in treating patients with mid-advanced pulmonary carcinoma.[Methods] Seventy-one cases with mid-advanced pulmonary carcinoma were divided into two groups: 1) control group,the treatment was performed by local perfusion chemotherapy only by a catheter inserted selectively into the arteries supplying tumors.2) treatment group,the treatment was performed with local perfusion chemotherapy combined with traditional Chinese medicine.[Results] In the control group the number of local perfusion chemotherapy performed was 109 with an average time of 2.9 per patient and the effective rate was 43.24%.In the treatment group the number of local perfusion chemotherapy performed was 134 with an average time of 4.3 per patient and the effective rate was 73.53% with a significant difference in effective rate between these two groups(P<0.05).There was a different degree improvement of clinical symptoms of patients in two groups.[Conclusion] The method of traditional Chinese medicine combined with local perfusion chemotherapy is superior to that of local perfusion chemotherapy only in treating mid-advanced pulmonary carcinoma and thus has a wide prospect. |
|
